However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock soaring Wednesday.

The S&P 500 dipped amid news of higher-than-expected U.S. inflation, dampening hopes for a Federal Reserve rate cut. Despite ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

Shares of CVS Health (NYSE: CVS) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.

CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS Health ended 2024 as it started, with high medical costs in the company’s insurance business chipping away at its bottom ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

U.S. stocks pared early losses on Wednesday but remained mostly lower after inflation data came in hotter than expected, potentially complicating the Federal Reserve's job of returning inflation to ...

CVS Health plans to shed enrollment by more than 1 million members this year, mostly in Medicare Advantage and individual ...

When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.